INBX — Inhibrx Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Inhibrx Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	131	274	278	153	124
Net Total Accounts Receivable
Net Total Receivables	0.878	0.257	0.778	0.42	0.177
Prepaid Expenses
Total Current Assets	139	280	295	160	133
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.49	7.22	9.37	13.5	9.27
Other Long Term Assets
Total Assets	150	291	308	181	146
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	22.5	27.6	56.3	40.7	33.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	98.1	233	264	47.2	138
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	52.4	58.1	43.5	134	7.99
Total Liabilities & Shareholders' Equity	150	291	308	181	146
Total Common Shares Outstanding